ロード中...
Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies
High levels of HDL cholesterol (HDL-C) have traditionally been linked to lower incidence of cardiovascular disease, prompting the search for effective and safe HDL-C raising pharmaceutical agents. Although drugs such as niacin and fibrates represent established therapeutic approaches, HDL-C response...
保存先:
| 出版年: | Expert Rev Cardiovasc Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347146/ https://ncbi.nlm.nih.gov/pubmed/23469915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/erc.12.134 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|